(M5S) Marna Beteiligungen - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A0H1GY2
M5S: Industrial, Chemicals, Materials, Investments, Partnerships, Acquisition
H2 Core AG, a German investment firm, specializes in the acquisition, management, and divestiture of corporate and partnership interests. The company, rebranded from MARNA Beteiligungen AG in June 2024, was established in 2006 and is headquartered in Heidelberg. Its primary focus is on strategic investments across various sectors, emphasizing long-term value creation.
As a key player in the specialty chemicals sector, H2 Core AG leverages its expertise to identify and capitalize on emerging opportunities. The firms approach typically involves active portfolio management, aiming to enhance operational efficiency and drive growth within its investments.
3-Month Forecast:
Based on the provided data, H2 Core AGs stock (M5S) is expected to face challenges in the upcoming quarter. The low average volume of 1,416 shares indicates limited liquidity, which could lead to higher volatility. The stock price has been declining, as evidenced by the SMA 20 (0.75), SMA 50 (0.76), and SMA 200 (1.45), suggesting a bearish trend. The ATR of 0.03 reflects low volatility, indicating a narrow trading range.
From a fundamental perspective, the companys high P/B ratio of 37.05 and extreme P/S ratio of 3,809.64 suggest that the market expects significant future growth despite current losses. However, the negative RoE of -54.57% indicates substantial profitability challenges. The lack of P/E and Forward P/E values suggests that the company is not generating earnings, which could impact investor sentiment.
Overall, the stock is likely to remain under pressure in the next three months, with limited upside potential due to its poor fundamental performance and bearish technical indicators.
Additional Sources for M5S Stock
M5S Stock Overview
Market Cap in USD | 6m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
M5S Stock Ratings
Growth 5y | -63.9% |
Fundamental | -24.0% |
Dividend | 0.0% |
Rel. Strength | -80.1 |
Analysts | - |
Fair Price Momentum | 0.37 EUR |
Fair Price DCF | 0.11 EUR |
M5S Dividends
No Dividends PaidM5S Growth Ratios
Growth Correlation 3m | -54.4% |
Growth Correlation 12m | -92.3% |
Growth Correlation 5y | -63.1% |
CAGR 5y | -52.21% |
CAGR/Max DD 5y | -0.60 |
Sharpe Ratio 12m | -0.06 |
Alpha | -81.96 |
Beta | 0.946 |
Volatility | 285.00% |
Current Volume | 5k |
Average Volume 20d | 4.6k |
As of April 07, 2025, the stock is trading at EUR 0.46 with a total of 5,000 shares traded.
Over the past week, the price has changed by -34.29%, over one month by -38.26%, over three months by -42.50% and over the past year by -82.96%.
Neither. Based on ValueRay Fundamental Analyses, Marna Beteiligungen is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -23.99 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of M5S as of April 2025 is 0.37. This means that M5S is currently overvalued and has a potential downside of -19.57%.
Marna Beteiligungen has no consensus analysts rating.
According to ValueRays Forecast Model, M5S Marna Beteiligungen will be worth about 0.4 in April 2026. The stock is currently trading at 0.46. This means that the stock has a potential downside of -10.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 2.2 | 378.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.4 | -10.9% |